Nathan is an experienced business development professional with a solid grounding in molecular immunology, focusing on cancer drug development. He excels in managing strategic accounts, with achievements including generating $2 to $7 million in quarterly revenue. Nathan's work spans across notable entities like The Jackson Laboratory and Crown Bioscience, where he has led initiatives in animal modeling, PK studies, and cell line generation. His ability to merge scientific innovation with commercial success, coupled with a strategic and relational approach, has notably advanced cancer treatment developments.Full resume and references are available upon request.